Estrogen receptor beta binds to and regulates three distinct classes of target genes.
Estrogen receptor beta (ERbeta) has potent antiproliferative and anti-inflammatory properties, suggesting that ERbeta-selective agonists might be a new class of therapeutic and chemopreventive agents. To understand how ERbeta regulates genes, we identified genes regulated by the unliganded and liganded forms of ERalpha and ERbeta in U2OS cells. Microarray data demonstrated that virtually no gene regulation occurred with unliganded ERalpha, whereas many genes were regulated by estradiol (E(2)). These results demonstrated that ERalpha requires a ligand to regulate a single class of genes. In contrast, ERbeta regulated three classes of genes. Class I genes were regulated primarily by unliganded ERbeta. Class II genes were regulated only with E(2), whereas class III genes were regulated by both unliganded ERbeta and E(2). There were 453 class I genes, 258 class II genes, and 83 class III genes. To explore the mechanism whereby ERbeta regulates different classes of genes, chromatin immunoprecipitation-sequencing was performed to identify ERbeta binding sites and adjacent transcription factor motifs in regulated genes. AP1 binding sites were more enriched in class I genes, whereas ERE, NFkappaB1, and SP1 sites were more enriched in class II genes. ERbeta bound to all three classes of genes, demonstrating that ERbeta binding is not responsible for differential regulation of genes by unliganded and liganded ERbeta. The coactivator NCOA2 was differentially recruited to several target genes. Our findings indicate that the unliganded and liganded forms of ERbeta regulate three classes of genes by interacting with different transcription factors and coactivators.
Vivar
Omar I
OI
Department of Nutritional Science and Toxicology, University of California, Berkeley, California 94720, USA.
Zhao
Xiaoyue
X
Saunier
Elise F
EF
Griffin
Chandi
C
Mayba
Oleg S
OS
Tagliaferri
Mary
M
Cohen
Isaac
I
Speed
Terence P
TP
Leitman
Dale C
DC
D020029:Base Pairing; D001665:Binding Sites; D045744:Cell Line, Tumor; D047369:Chromatin Immunoprecipitation; D019295:Computational Biology; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D015894:Genome, Human / Q000235:genetics; D006801:Humans; D008024:Ligands; D051958:Nuclear Receptor Coactivator 2 / Q000378:metabolism; D011485:Protein Binding / Q000235:genetics; D018808:Transcription Factor AP-1 / Q000378:metabolism
C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D008024:Ligands; C498001:NCOA2 protein, human; D051958:Nuclear Receptor Coactivator 2; D018808:Transcription Factor AP-1
Mol Endocrinol. 2006 Aug;20(8):1707-14
16396959
Endocrinology. 2001 Sep;142(9):4120-30
11517191
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11162-6
8248223
Physiol Rev. 2007 Jul;87(3):905-31
17615392
Nat Genet. 2006 Nov;38(11):1289-97
17013392
Endocr Rev. 2007 Aug;28(5):575-87
17609497
Endocr Relat Cancer. 2009 Jun;16(2):381-9
19369485
Genome Biol. 2008;9(9):R137
18798982
Nature. 2009 Nov 5;462(7269):58-64
19890323
Adv Pharmacol. 2000;47:89-112
10582085
Mol Endocrinol. 2008 Feb;22(2):287-303
17962382
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1566-71
14745018
Mol Endocrinol. 2005 Aug;19(8):1951-9
15705661
Nat Biotechnol. 2008 Nov;26(11):1293-300
18978777
EMBO J. 2009 May 20;28(10):1418-28
19339991
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6694-9
12740446
J Cell Biochem. 2003 Oct 1;90(2):315-26
14505348
Nucleic Acids Res. 2000 Jan 1;28(1):316-9
10592259
J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):311-7
11162939
Cancer Res. 2004 Jan 1;64(1):423-8
14729654
Nat Rev Cancer. 2007 Sep;7(9):713-22
17721435
J Immunol. 2008 Jan 1;180(1):630-6
18097065
Mol Endocrinol. 2008 Nov;22(11):2393-406
18818283
J Biol Chem. 2000 Feb 25;275(8):5379-87
10681512
Cell. 1998 Dec 23;95(7):927-37
9875847
Cell. 2003 Dec 12;115(6):751-63
14675539
Cell. 2005 Jul 15;122(1):33-43
16009131
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
Mol Biol Cell. 2004 Mar;15(3):1262-72
14699072
Annu Rev Physiol. 2005;67:309-33
15709961
Nature. 2008 Dec 4;456(7222):663-6
19005469
Cancer Res. 2006 Dec 1;66(23):11207-13
17145865
Endocr Rev. 2002 Jun;23(3):279-302
12050121
Endocr Rev. 2004 Feb;25(1):45-71
14769827
Endocrinology. 2007 Feb;148(2):538-47
17095596
Mol Cell Endocrinol. 2010 Feb 5;315(1-2):201-7
19744542
Mol Cell. 2006 Feb 17;21(4):555-64
16483936
Endocrinology. 2010 Apr;151(4):1662-7
20160136
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
N Engl J Med. 1999 Jun 10;340(23):1801-11
10362825
Bioinformatics. 2008 Jul 1;24(13):1547-8
18467348
Cell. 2000 Dec 8;103(6):843-52
11136970
Cancer Res. 2009 Aug 1;69(15):6100-6
19602591
Annu Rev Physiol. 2005;67:285-308
15709960
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15677-82
9861029
Recent Prog Horm Res. 2000;55:163-93; discussion 194-5
11036937
Biochem Pharmacol. 2009 Sep 1;78(5):469-76
19433067